1
|
Material Type: Web Resource
|
|
Commentary: All scholarship families deserve spending flexibility
redefinED (Blogs on Demand), 2021
Newstex LLC
Sem texto completo
|
2
|
Material Type: Web Resource
|
|
The Unknown Puts Offspring At Risk Of Sickle Cell Disease
C-HIT (Blogs on Demand), 2022
Newstex LLC
Sem texto completo
|
3
|
Material Type: Web Resource
|
|
Imara Reveals IPO Plan as Sickle Cell Drug Advances in the Clinic
Xconomy (Blogs on Demand), 2020
Newstex LLC
Sem texto completo
|
4
|
Material Type: Web Resource
|
|
Two Big Pharma Alliances End in Nixed Deals. Here's What Happened
Xconomy (Blogs on Demand), 2020
Newstex LLC
Sem texto completo
|
5
|
Material Type: Web Resource
|
|
Aruvant Taps Sarepta's Palaniappan as Chief Technology Officer
Xconomy (Blogs on Demand), 2020
Newstex LLC
Sem texto completo
|
6
|
Material Type: Web Resource
|
|
Global Blood's Sickle Cell Drug Wins FDA Approval Ahead of Schedule
Xconomy (Blogs on Demand), 2019
Newstex LLC
Sem texto completo
|
7
|
Material Type: Web Resource
|
|
CRISPR gene editing shows promise for sickle cell disease
Engadget HD (Blogs on Demand), 2020
Newstex LLC
Sem texto completo
|
8
|
Material Type: Web Resource
|
|
Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs
Xconomy (Blogs on Demand), 2020
Newstex LLC
Sem texto completo
|